Exelixis (EXEL) CFO Christopher Senner awarded 52,018 RSU-based shares

Rhea-AI Filing Summary

EXELIXIS, INC. Executive Vice President and CFO Christopher J. Senner reported an equity compensation award in the form of restricted stock units tied to the company’s common stock. The filing shows an acquisition of 52,018 shares of common stock at a price of $0.00 per share, representing RSUs granted under the Exelixis, Inc. 2017 Equity Incentive Plan that will be issued upon vesting. These RSUs vest in four equal annual installments, beginning May 15, 2027 and then each May 15 thereafter until fully vested. After this grant, Senner directly owns or has rights to 1,028,110 shares of common stock, including 479,708 shares that will be issued upon vesting of previously granted RSUs and performance-based restricted stock units. He also indirectly holds 2,723 shares through the Exelixis, Inc. 401(k) Plan as of February 26, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Senner Christopher J.

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CA 94502

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026(1)		A		52,018(1)	A	$0	1,028,110(2)	D
Common Stock								2,723(3)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested.

2. Includes 479,708 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

3. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 26, 2026.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did EXEL (Exelixis) EVP and CFO Christopher Senner report on this Form 4?

Christopher J. Senner reported an equity compensation grant tied to Exelixis common stock. The filing shows he acquired 52,018 RSU-based shares at $0.00 per share, awarded under the company’s 2017 Equity Incentive Plan on February 26, 2026.

How many Exelixis (EXEL) shares were granted to Christopher Senner in this award?

The award covers 52,018 shares of Exelixis common stock issuable upon vesting of restricted stock units. These RSUs were granted on February 26, 2026 and are part of Senner’s compensation, rather than an open-market stock purchase.

What is the vesting schedule for Christopher Senner’s new Exelixis RSUs?

The 52,018 RSUs vest over four years. One-quarter vests on May 15, 2027, and an additional quarter vests on each following May 15 until the award is fully vested, assuming continued service and plan conditions.

How many Exelixis shares does Christopher Senner own or have rights to after this Form 4?

After the grant, Senner has 1,028,110 shares directly owned or subject to equity awards, including 479,708 shares tied to RSUs and performance-based units. He also indirectly holds 2,723 shares through the Exelixis 401(k) Plan as of February 26, 2026.

Does this Exelixis (EXEL) Form 4 show any stock sales by Christopher Senner?

The filing does not report any stock sales. It shows an acquisition via restricted stock unit grant and updated holdings, including direct equity awards and shares held indirectly in the company’s 401(k) Plan as of the reported date.

What are the One-Time Award PSUs mentioned in Christopher Senner’s Exelixis holdings?

The filing notes performance-based restricted stock units granted on March 31, 2025, called One-Time Award PSUs. Each represents a contingent right to receive one Exelixis share, contributing to the 479,708 shares that may be issued upon vesting.